Your browser doesn't support javascript.
loading
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy.
Bacon, Jack V W; Müller, David C; Ritch, Elie; Annala, Matti; Dugas, Sarah G; Herberts, Cameron; Vandekerkhove, Gillian; Seifert, Helge; Zellweger, Tobias; Black, Peter C; Bubendorf, Lukas; Wyatt, Alexander W; Rentsch, Cyrill A.
Affiliation
  • Bacon JVW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Müller DC; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Ritch E; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Annala M; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland.
  • Dugas SG; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Herberts C; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Vandekerkhove G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Seifert H; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Zellweger T; St. Claraspital, Basel, Switzerland.
  • Black PC; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Wyatt AW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada. Electronic address: awwyatt@mail.ubc.ca.
  • Rentsch CA; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland. Electronic address: cyrill.rentsch@usb.ch.
Eur Urol Oncol ; 5(6): 677-686, 2022 12.
Article in En | MEDLINE | ID: mdl-34895867
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Non-Muscle Invasive Bladder Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Urol Oncol Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Non-Muscle Invasive Bladder Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Urol Oncol Year: 2022 Type: Article Affiliation country: Canada